相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in Glucose Homeostasis after Roux-en-Y Gastric Bypass Surgery for Obesity at Day Three, Two Months, and One Year after Surgery: Role of Gut Peptides
Y. Falken et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study
Ole-Petter R. Hamnvik et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Effects of leptin and adiponectin on pancreatic β-cell function
Yong-ho Lee et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Comparison of Glucostatic Parameters After Hypocaloric Diet or Bariatric Surgery and Equivalent Weight Loss
Leona Plum et al.
OBESITY (2011)
Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy
Wei-Jei Lee et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2011)
Nutrition and L and K-enteroendocrine cells
Ruth Gutierrez-Aguilar et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2011)
A Multicenter, Randomized Efficacy Study of the EndoBarrier Gastrointestinal Liner for Presurgical Weight Loss Prior to Bariatric Surgery
Ruben Schouten et al.
ANNALS OF SURGERY (2010)
DURATION-1 Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
John B. Buse et al.
DIABETES CARE (2010)
Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study
R. Ratner et al.
DIABETIC MEDICINE (2010)
Changes in Gastrointestinal Hormones and Leptin after Roux-en-Y Gastric Bypass Procedure: A Review
Lauren M. Beckman et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2010)
Role of Leptin in the Activation of Immune Cells
Patricia Fernandez-Riejos et al.
MEDIATORS OF INFLAMMATION (2010)
Effects of meal size and composition on incretin, α-cell, and β-cell responses
Josina M. Rijkelijkhuizen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis
Tomoyuki Kawada
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Long-Term Results of Bariatric Restrictive Procedures: A Prospective Study
Ruben Schouten et al.
OBESITY SURGERY (2010)
Regulation of adipokine secretion by n-3 fatty acids
Maria J. Moreno-Aliaga et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2010)
Proghrelin peptides: Desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin A study of pancreatic polypeptide secretion from mouse islets
Rajesh Kumar et al.
REGULATORY PEPTIDES (2010)
Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes
Ulrich Werner et al.
REGULATORY PEPTIDES (2010)
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Henry Buchwald et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion
Mi-Jeong Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism
Remy Burcelin et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes A randomized controlled trial exploring weekly, biweekly, and monthly dosing
Julio Rosenstock et al.
DIABETES CARE (2009)
Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion
G. Mingrone et al.
DIABETOLOGIA (2009)
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Jonathan W. Day et al.
NATURE CHEMICAL BIOLOGY (2009)
Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects
Rosa Morinigo et al.
ANNALS OF SURGERY (2008)
Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy - A prospective, double blind study
Stavros N. Karamanakos et al.
ANNALS OF SURGERY (2008)
Changes in gut hormones after bariatric surgery
R. P. Vincent et al.
CLINICAL ENDOCRINOLOGY (2008)
Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: A proof-of-concept study in healthy subjects
C. Beglinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity
Cendrine Cabou et al.
DIABETES (2008)
Postprandial changes in gut regulatory peptides in gastric bypass patients
C. Holdstock et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance
Michaela Riedl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release
Frederique Rodieux et al.
OBESITY (2008)
Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity
Royce P. Vincent et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss
Thomas Reinehr et al.
OBESITY SURGERY (2007)
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal
A. B. Goldfine et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
Carel W. le Roux et al.
ANNALS OF SURGERY (2007)
Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding
Judith Korner et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2007)
Plasma ghrelin and gastric pacing in morbidly obese patients
Valerio Cigaina et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes
Blandine Laferrere et al.
DIABETES CARE (2007)
Gut hormones and appetite control
A. M. Wren et al.
GASTROENTEROLOGY (2007)
Early changes in ghrelin following Roux-en-Y gastric bypass:: Influence of vagal nerve functionality?
Magnus Sundbom et al.
OBESITY SURGERY (2007)
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial
K. Wynne et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Non-alcoholic steatohepatitis: Effect of Roux-en-Y gastric bypass surgery
KB Barker et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system
Erdal Budak et al.
FERTILITY AND STERILITY (2006)
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters
CW le Roux et al.
ANNALS OF SURGERY (2006)
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects - A double-blind, randomized, controlled trial
K Wynne et al.
DIABETES (2005)
Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy
CW le Roux et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Blockade of the neuropeptide YY2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake
CR Abbott et al.
BRAIN RESEARCH (2005)
Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY
S Schonhoff et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Peripheral administration of PYY3-36 produces conditioned taste aversion in mice
IG Halatchev et al.
CELL METABOLISM (2005)
Role of the duodenum and macronutrient type in ghrelin regulation
J Overduin et al.
ENDOCRINOLOGY (2005)
Current knowledge in the neurophysiologic modulation of obesity
N Angelopoulos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Update on adipocyte hormones - Regulation of energy balance and carbohydrate/lipid metabolism
PJ Havel
DIABETES (2004)
Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin
U Meier et al.
CLINICAL CHEMISTRY (2004)
The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism
F Rubino et al.
ANNALS OF SURGERY (2004)
Effects of PYY[3-36] in rodent models of diabetes and obesity
RA Pittner et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines:: Relationships in obesity
J Vendrell et al.
OBESITY RESEARCH (2004)
On the physiology of GIP and GLP-1
JJ Holst
HORMONE AND METABOLIC RESEARCH (2004)
Gastric bypass for obesity: Mechanisms of weight loss and diabetes resolution
DE Cummings et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Peripheral oxyntomodulin reduces food intake and body weight gain in rats
CL Dakin et al.
ENDOCRINOLOGY (2004)
Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein
HY Chen et al.
ENDOCRINOLOGY (2004)
Oxyntomodulin suppresses appetite and reduces food intake in humans
MA Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Insulin resistance, leptin and TNF-α system in morbidly obese women after gastric bypass
A Molina et al.
OBESITY SURGERY (2003)
Antagonism of ghrelin receptor reduces food intake and body weight gain in mice
A Asakawa et al.
GUT (2003)
Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content
M Tiikkainen et al.
DIABETES (2003)
Hormonal control of the neuropeptide Y system
P Magni
CURRENT PROTEIN & PEPTIDE SCIENCE (2003)
Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women
P Monteleone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Hypothalamic regulation of energy homeostasis
A Sainsbury et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Gut hormone PYY3-36 physiologically inhibits food intake
RL Batterham et al.
NATURE (2002)
Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats
N Murakami et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
K Miyawaki et al.
NATURE MEDICINE (2002)
Intracellular signalling - Key enzyme in leptin-induced anorexia
KD Niswender et al.
NATURE (2001)
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans
H Ariyasu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction
C Verdich et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
DE Cummings et al.
DIABETES (2001)
Soluble leptin receptor represents the main leptin binding activity in human blood
A Lammert et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro
DG Parkes et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
A role for ghrelin in the central regulation of feeding
M Nakazato et al.
NATURE (2001)
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans
Y Date et al.
ENDOCRINOLOGY (2000)
Ghrelin induces adiposity in rodents
M Tschöp et al.
NATURE (2000)
分享论文
